Your browser doesn't support javascript.
loading
Association between Familial Hypercholesterolemia and Serum Levels of Cholesterol Synthesis and Absorption Markers: The CACHE Study FH Analysis.
Matsuki, Kota; Harada-Shiba, Mariko; Hori, Mika; Ogura, Masatsune; Akiyama, Yusuke; Fujii, Hisako; Ishibashi, Yutaka; Ishida, Tatsuro; Ishigaki, Yasushi; Kabata, Daijiro; Kihara, Yasuki; Kotani, Kazuhiko; Kurisu, Satoshi; Masuda, Daisaku; Matoba, Tetsuya; Matsumura, Takeshi; Mori, Kenta; Nakagami, Tomoko; Nakazato, Masamitsu; Taniuchi, Satsuki; Ueno, Hiroaki; Yamashita, Shizuya; Yoshida, Hiroshi; Yoshida, Hisako; Shoji, Tetsuo.
Afiliación
  • Matsuki K; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
  • Harada-Shiba M; Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki.
  • Hori M; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
  • Ogura M; Cardiovascular Center, Osaka Medical and Pharmaceutical University.
  • Akiyama Y; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
  • Fujii H; Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University.
  • Ishibashi Y; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
  • Ishida T; Department of General Medical Science, Chiba University Graduate School of Medicine.
  • Ishigaki Y; Department of Cardiovascular, Respiratory and Geriatric Medicine, Kyushu University Beppu Hospital.
  • Kabata D; Department of Health and Medical Innovation, Osaka Metropolitan University Graduate School of Medicine.
  • Kihara Y; Department of General Medicine, Shimane University Faculty of Medicine.
  • Kotani K; Jinjyukai Education & Training Center for Healthcare Professionals.
  • Kurisu S; Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine.
  • Masuda D; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University.
  • Matoba T; Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine.
  • Matsumura T; Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Mori K; Division of Community and Family Medicine, Jichi Medical University.
  • Nakagami T; Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • Nakazato M; Rinku General Medical Center.
  • Taniuchi S; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University.
  • Ueno H; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University.
  • Yamashita S; Department of General Internal Medicine, Kobe University Hospital.
  • Yoshida H; Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine.
  • Yoshida H; Department of Bioregulatory Sciences, Faculty of Medicine, University of Miyazaki.
  • Shoji T; Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine.
J Atheroscler Thromb ; 30(9): 1152-1164, 2023 Sep 01.
Article en En | MEDLINE | ID: mdl-36624055
ABSTRACT

AIM:

Serum levels of cholesterol absorption and synthesis markers are known to be associated with cardiovascular risk. Familial hypercholesterolemia (FH) is a well-known inherited disorder presenting elevated low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) levels and premature coronary disease. In this study, we aim to examine the differences in terms of serum markers of cholesterol metabolism between FH and non-FH individuals and to examine their associations with serum lipid levels.

METHODS:

In this study, we utilized data on serum markers of cholesterol metabolism, namely, lathosterol (Latho, synthesis marker), campesterol (Campe, absorption marker), and sitosterol (Sito, absorption marker) measured by gas chromatography of the CACHE consortium, which comprised of 13 research groups in Japan. Clinical data were compiled using REDCap system. Among the 2944 individuals in the CACHE population, we selected individuals without lipid-lowering medications and hemodialysis patients for this CACHE study FH analysis. Multivariable adjustment was performed to assess the associations.

RESULTS:

In this study, we analyzed data from 51 FH patients and 1924 non-FH individuals. After adjustment for possible confounders, the FH group was shown to have significantly higher Campe and Sito concentrations and insignificantly higher Latho concentrations than the non-FH group. These marker concentrations showed nonlinear associations with TC in the FH group. Campe/Latho and Sito/Latho ratios were significantly higher in the FH group than in the non-FH group.

CONCLUSION:

FH group had significantly elevated serum Campe and Sito concentrations and insignificantly elevated Latho concentrations; thus, intestinal cholesterol absorption relative to hepatic cholesterol synthesis was suggested to be elevated in patients with FH. Serum Latho, Campe, and Sito concentrations showed nonlinear associations with TC in the FH group.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Hiperlipoproteinemia Tipo II Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Atheroscler Thromb Asunto de la revista: ANGIOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Hiperlipoproteinemia Tipo II Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Atheroscler Thromb Asunto de la revista: ANGIOLOGIA Año: 2023 Tipo del documento: Article